Dose- and gender-dependent interactions between coffee consumption and serum GGT activity in alcohol consumers

Alcohol and Alcoholism

Volumn 48, Issue 3, 2013, Pages 303-307

  Danielsson, Joanna ^a   Kangastupa, Päivikki ^a   Laatikainen, Tiina ^b,c   Aalto, Mauri ^a,b   Niemelä, Onni ^a  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COFFEE; CROSS-SECTIONAL STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; ENZYME ACTIVITY; FEMALE; GENDER; HEALTH SURVEY; HUMAN; MALE; PRIORITY JOURNAL; SMOKING;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; COFFEE; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FINLAND; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEX CHARACTERISTICS; SMOKING; YOUNG ADULT;

EID: 84877111505     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agt017     Document Type: Article

References (51)

1. Agardh EE, Carlsson S, Ahlbom A et al. (2004) Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 255:645-52.
2. Alatalo PI, Koivisto HM, Hietala JP et al. (2008) Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 88:1097-103.
3. Alatalo PI, Koivisto HM, Hietala JP et al. (2009) Gender-dependent impacts of body mass index and moderate alcohol consumption on serum uric acid-an index of oxidant stress status? Free Radic Biol Med 46:1233-8.
4. Arnesen E, Huseby NE, Brenn T, et al. (1986) The Tromso Heart Study: distribution of, and determinants for, gammaglutamyltransferase in a free-living population. Scand J Clin Lab Invest 46:63-70.
5. Bidel S, Hu G, Qiao Q et al. (2006) Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia 49:2618-26.
6. Bidel S, Silventoinen K, Hu G et al. (2008) Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr 62:178-85.
7. Breitling LP, Raum E, Müller H et al. (2009) Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 49:802-8.
8. Casiglia E, Spolaore P, Ginocchio G et al. (1993) Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 9:293-7.
9. Corrao G, Bagnardi V, Zambon A et al. (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38:613-9.
10. Costentin CE, Roudot-Thoraval F, Zafrani ES et al. (2011) Association of caffeine intake and histological features of chronic hepatitis C. J Hepatol 54:1123-9.
11. Dey A, Cederbaum AI. (2006) Alcohol and oxidative liver injury. Hepatology 43:S63-S74.
12. Emdin M, Pompella A, Paolicchi A. (2005) Gammaglutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112:2078-80.
13. Floegel A, Pischon T, Bergmann MM et al. (2012) Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr 95:901-8.
14. Freedman ND, Everhart JE, Lindsay KL et al. (2009) Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 50:1360-9.
15. Freedman ND, Park Y, Abnet CC et al. (2012) Association of coffee drinking with total and cause-specific mortality. N Engl J Med 366:1891-904.
16. Grassi F, Tell G, Robbie-Ryan M et al. (2007) Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA 104:15087-92.
17. Gressner OA (2009) Less Smad2 is good for you! A scientific update on coffee's liver benefits. Hepatology 50:970-8.
18. Gunzerath L, Faden V, Zakhari S et al. (2004) National Institute on Alcohol Abuse and Alcoholism report on moderate drinking. Alcohol Clin Exp Res 28:829-47.
19. Higdon JV, Frei B. (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101-23.
20. Hu G, Tuomilehto J, Pukkala E et al. (2008) Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology 48:129-36.
21. Huber WW, Scharf G, Rossmanith W et al. (2002) The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol 75:685-94.
22. Ikeda M, Maki T, Yin G et al. (2010) Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index. Scand J Clin Lab Invest 70:171-9.
23. Inoue M, Yoshimi I, Sobue T et al. (2005) Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 97:293-300.
24. Kazemi-Shirazi L, Endler G, Winkler S et al. (2007) Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem 53:940-6.
25. Kendrick SF, Day CP. (2007) A coffee with your brandy, sir? J Hepatol 46:980-2.
26. Klatsky AL, Armstrong MA. (1992) Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 136:1248-57.
27. Klatsky AL, Morton C, Udaltsova N et al. (2006) Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 166:1190-5.
28. Kozakova M, Palombo C, Eng MP et al. (2012) Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology 55:1406-15.
29. Lança AJ, Israel Y. (1991) Histochemical demonstration of sinusoidal gamma-glutamyltransferase activity by substrate protection fixation: comparative studies in rat and guinea pig liver. Hepatology 14:857-63.
30. Lee DH, Jacobs DR, Jr, Gross M et al. (2003) Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49:1358-66.
31. Lee DH, Blomhoff R, Jacobs DR, Jr. (2004) Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535-9.
32. Lee DH, Ha MH, Kam S et al. (2006a) A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol 163:57-65.
33. Lee DH, Silventoinen K, Hu G et al. (2006b) Serum gammaglutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 27:2170-6.
34. Leino A, Impivaara O, Irjala K et al. (1995) Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European Committee for Clinical Laboratory Standards (ECCLS). Scand J Clin Lab Invest 55:243-50.
35. Mason JE, Starke RD, Van Kirk JE. (2010) Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 13:36-41.
36. Mistry D, Stockley RA. (2010) Gamma-glutamyl transferase: the silent partner? COPD 7:285-90.
37. Modi AA, Feld JJ, Park Y et al. (2010) Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 51:201-9.
38. Nilssen O, Førde O, Brenn T. (1990) The Tromso Study. Distribution and population determinants of gammaglutamyltransferase. Am J Epidemiol 132:318-26.
39. Poikolainen K, Vartiainen E. (1997) Determinants of gammaglutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol 146:1019-24.
40. Ruhl CE, Everhart JE. (2005) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129:1928-36.
41. Ruttmann E, Brant LJ, Concin H et al. The Vorarlberg Health Monitoring and Promotion Program Study Group. (2005) Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130-7.
42. Ryu S, Chang Y, Woo HY et al. (2010) Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men. Metabolism 59:683-9.
43. Shimazu T, Tsubono Y, Kuriyama S et al. (2005) Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 116:150-4.
44. Speisky H, MacDonald A, Giles G et al. (1985) Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration. Turnover studies. Biochem J 225:565-72.
45. Tanaka K, Tokunaga S, Kono S et al. (1998) Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 27:438-43.
46. Targher G. (2010) Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer-a narrative review. Clin Chem Lab Med 48:147-57.
47. Tverdal A, Skurtveit S. (2003) Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 13:419-23.
48. Tynjälä J, Kangastupa P, Laatikainen T et al. (2012) Effect of age and gender on the relationship between alcohol consumption and serum GGT: time to recalibrate goals for normal ranges. Alcohol Alcohol 47:558-62.
49. Vitaglione P, Morisco F, Mazzone G et al. (2010) Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 52:1652-61.
50. The World Health Organization (1988) The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 41:105-14.
51. Zhang H, Forman HJ. (2009) Redox regulation of gamma-glutamyl transpeptidase. Am J Respir Cell Mol Biol 41:509-15.